Related Experiment Video
Updated: Oct 15, 2026

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome
Published on: October 3, 2018
[Malignant clonogenic precursors in the peripheral blood of patients with multiple myeloma]
1Department of Hematology, 2nd Affiliated Hospital of Zhejiang Medical University, Hangzhou.
Objective:
To study the clonogenic potential of circulating malignant precursors in the peripheral blood of patients with multiple myeloma (MM).
Methods:
A new cell culture system was used to expand putative malignant precursor clones and promote their differentiation. Meanwhile, immunocytochemical staining, Giemsa-Wright staining and scanning electron microscopy were employed to reveal the growth properties and biological features of fresh and expanded malignant precursors and plasmacytes.
Results:
Small lymphocyte-like B cells, which were actively proliferative and grew in the form of clusters, were found at the third day after culture. They accounted for 38% +/- 14%. The cells didn't express cytoplasmic immunoglobulin (CyIg) and CD38 antigen. In addition, no typical plasmacytes were observed. At the sixth day of culture, morphologically discernible plasmacytes, which grew in the form of large clumps in this culture system, were detected and represented 58% +/- 8%. These plasmacytes strongly expressed CD38 antigen and monoclonal CyIg identical to that of the original myeloma cells.
Conclusion:
Malignant clonogenic precursor cells, which have high proliferative potential, are present in the peripheral blood of MM cases, and could proliferate and differentiate into myeloma cells.
Related Concept Videos
Differentiation of Common Myeloid Progenitor Cells
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Cells of the Adaptive Immune Response
Disorders of Leukocytes
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...
